TScan Therapeutics Announces Best Abstracts Award and Upcoming Oral Presentation at the 2024 ...

Presentation to include additional results from ongoing Phase 1 study of TSC-100 and TSC-101 for the treatment of heme malignancies

Related Keywords

Texas ,United States ,San Antonio ,American ,Jim Murray ,Jyun Wang ,Nishant Dwivedi ,Monzrm Al Malki ,Joyce Allaire ,Debora Barton ,Hyungc Suh ,Gavin Macbeath ,Nina Abelowitz ,Udayr Popat ,Henryb Gonz ,Heather Savelle ,Shrikanta Chattopadhyay ,Erica Buonomo ,Ashishs Kothari ,Lifesci Advisors ,International Blood ,Company Investor Relations ,Marrow Transplant Research ,Globe Newswire Tscan Therapeutics Inc ,Nasdaq ,Securities Exchange ,Tscan Therapeutics Inc ,Best Abstracts ,Tandem Meetings ,Cellular Therapy Meetings ,American Society ,Cellular Therapy ,Alla Keyzner ,Tandem Meetings Best ,Ballroom Level ,Investor Relations ,Private Securities Litigation Reform Act ,Securities Exchange Act ,Financial Condition ,Annual Report ,Sci Advisors ,Region ,